The Ministry of Health has signed a contract for the purchase of the Evusheld antibody produced by the AstraZeneca pharmaceutical company, which is used as a passive vaccine for immunodeficient individuals.
According to a source involved in the agreement, about 12,000 doses suitable for injection directly into the bloodstream are expected to reach Israel soon.